Rabbit anti-Human RCHY1 Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-01947A
Western blot  | All lanes: RCHY1 antibody at 3.98µg/ml  | Lane 1: SH-SY5Y whole cell lysate  | Lane 2: 293T whole cell lysate  | Lane 3: Hela whole cell lysate  | Secondary  | Goat polyclonal to rabbit IgG at 1/10000 dilution  | Predicted band size: 31, 29, 21, 22, 9, 28, 26, 25 kDa  | Observed band size: 31 kDa
Western blot | All lanes: RCHY1 antibody at 3.98µg/ml | Lane 1: SH-SY5Y whole cell lysate | Lane 2: 293T whole cell lysate | Lane 3: Hela whole cell lysate | Secondary | Goat polyclonal to rabbit IgG at 1/10000 dilution | Predicted band size: 31, 29, 21, 22, 9, 28, 26, 25 kDa | Observed band size: 31 kDa
Immunohistochemistry of paraffin-embedded human liver tissue using RCHY1 Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human liver tissue using RCHY1 Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human gastric cancer using RCHY1 Antibody at dilution of 1:100
Immunohistochemistry of paraffin-embedded human gastric cancer using RCHY1 Antibody at dilution of 1:100

Rabbit anti-Human RCHY1 Polyclonal Antibody

Beta LifeScience SKU/CAT #: BLC-01947A
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.

Product Overview

Product Title Rabbit anti-Human RCHY1 Polyclonal Antibody
Description The antibody against RCHY1 was raised in rabbit using the Recombinant Human RING finger and CHY zinc finger domain-containing protein 1 protein (1-261AA) as the immunogen. This antibody exists as a non-conjugated isotype IgG, Antigen affinity purified. This antibody has been validated on ELISA, WB, IHC.
Uniprot Id - Alink Q96PM5
Host Species Rabbit
Reactivity Human
Target Name RCHY1
Target Synonyms Androgen receptor N terminal interacting protein antibody; Androgen receptor N-terminal-interacting protein antibody; ARNIP antibody; CH-rich-interacting match with PLAG1 antibody; CHIMP antibody; E3 ubiquitin-protein ligase Pirh2 antibody; hARNIP antibody; hPirh2 antibody; p53 induced protein with a RING H2 domain antibody; p53-induced RING-H2 protein antibody; PIRH2E antibody; PIRH2F antibody; PRO1996 antibody; RCHY1 antibody; Ring finger and CHY zinc finger domain containing 1 E3 ubiquitin protein ligase antibody; RING finger and CHY zinc finger domain-containing protein 1 antibody; RING finger protein 199 antibody; RNF199 antibody; ZCHY antibody; ZFP 363 antibody; zinc finger CHY type antibody; Zinc finger protein 363 antibody; ZN363_HUMAN antibody; ZNF363 antibody
Immunogen Description Recombinant Human RING finger and CHY zinc finger domain-containing protein 1 protein (1-261AA)
Immunogen Species Human
Immunogen Sequence Complete sequences for the immunogen, target protein, and peptides are available upon request.
Conjugate Non-conjugated
Clonality Polyclonal
Isotype IgG
Purification Method Antigen affinity purified
Buffer PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form Liquid
Application ELISA, WB, IHC
Storage Conditions Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

FAQs

Please fill out the Online Inquiry form located on the product page. Key product information has been pre-populated. You may also email your questions and inquiry requests to sales1@betalifesci.com. We will do our best to get back to you within 4 business hours.

Feel free to use the Chat function to initiate a live chat. Our customer representative can provide you with a quote immediately.

Proteins are sensitive to heat, and freeze-drying can preserve the activity of the majority of proteins. It improves protein stability, extends storage time, and reduces shipping costs. However, freeze-drying can also lead to the loss of the active portion of the protein and cause aggregation and denaturation issues. Nonetheless, these adverse effects can be minimized by incorporating protective agents such as stabilizers, additives, and excipients, and by carefully controlling various lyophilization conditions.

Commonly used protectant include saccharides, polyols, polymers, surfactants, some proteins and amino acids etc. We usually add 8% (mass ratio by volume) of trehalose and mannitol as lyoprotectant. Trehalose can significantly prevent the alter of the protein secondary structure, the extension and aggregation of proteins during freeze-drying process; mannitol is also a universal applied protectant and fillers, which can reduce the aggregation of certain proteins after lyophilization.

Our protein products do not contain carrier protein or other additives (such as bovine serum albumin (BSA), human serum albumin (HSA) and sucrose, etc., and when lyophilized with the solution with the lowest salt content, they often cannot form A white grid structure, but a small amount of protein is deposited in the tube during the freeze-drying process, forming a thin or invisible transparent protein layer.

Reminder: Before opening the tube cap, we recommend that you quickly centrifuge for 20-30 seconds in a small centrifuge, so that the protein attached to the tube cap or the tube wall can be aggregated at the bottom of the tube. Our quality control procedures ensure that each tube contains the correct amount of protein, and although sometimes you can't see the protein powder, the amount of protein in the tube is still very precise.

To learn more about how to properly dissolve the lyophilized recombinant protein, please visit Lyophilization FAQs.

Recently viewed